With a 96-inch wingspan and the uncanny ability — at a height of 7’4” — to not just dunk the ball but also hit 3-pointers, “Wemby” (Victor Wembanyama) of the San Antonio @Spurs, is widely rumored to be a space Alien.
I am not authorized to comment further.
Proud to lead 🫀 transplant @UCSFSurgery@UCSFHospitals
For May: 6 HTx in 3 days, 11 for the month. Record shattering 💥All with exceptional outcomes.
This is the result of surgical excellence, innovation, and an elite team working tirelessly for our pts
👏👏🫀🫀💪
‼️The American Surgical Association bestowed the prestigious 2⃣0⃣2⃣6⃣ Flance-Karl Award upon @UCSFTransplant Surgeon Dr. Sandy Feng (@SandyFeng8) — our Vice Chair of Research — recognizing research with lasting clinical impact on the field of transplantation👏
Presented at #ATS2026:
Among patients with idiopathic pulmonary fibrosis, inhaled treprostinil led to a smaller decline in forced vital capacity than placebo over 52 weeks. Cough and drug discontinuation were more common with treprostinil. Full results of the phase 3 TETON-1 and TETON-2 trials: https://t.co/uEmNsx7ylp
@atscommunity
More than a decade of NIH-funded work from the lab of UCSF's Kevan Shokat led up to this breakthrough. He found a way to create drugs against a mutation that appears in 20% of all cancers, including pancreatic, colon, and lung.
Dr. Aaron Baugh, a Black pulmonologist in California, believed that using race-correction in lung-function tests was a way to reduce health inequities. That was until he ran the numbers himself. Shocked by the results, he began to study the harmful effects of race correction on Black patients with lung disease.
Part two of 𝙏𝙝𝙚 𝙍𝙖𝙘𝙚 𝙀𝙦𝙪𝙖𝙩𝙞𝙤𝙣 uncovers the racist myths that led to today’s lung-function testing with Harvard historian of science Evelynn Hammonds and Brown professor Lundy Braun. Why is the race-corrected interpretation of spirometer test results still used by a majority of U.S. hospitals, when scientists have documented that the practice is harming patients?
Explore this topic in the latest episode of the Intention to Treat podcast: https://t.co/0CqRWfGg4C
Proud to be a part of this important effort defining a clinical syndrome with real implications for patient diagnosis, management, and as a clinical trial entry point.
This researcher created a fictional illness, and fake studies funded by the Professor Sideshow Bob Foundation and University of the Fellowship of the Ring and the Galactic Triad.
LLMs warned people the illness was real.
https://t.co/7rQT7252oa
A potentially game-changing discovery by @UCSF's Justin Eyquem @j_eyquem & colleagues – injecting cancer-fighting immune cells directly into the body kills several types of cancers in mice.
Paper in @Nature: https://t.co/EXbsfx7whl Summary/video by UCSF: https://t.co/qLYXXvEDTV
We have a post doc opening in the Calabrese Lab, please consider applying if interested in transplant immunology and lung injury! https://t.co/XhyYYxN4bj
📢 A NEW #ISHLT Consensus Statement on the considerations for endpoints in #LungTransplantation clinical trials is now available. 📖💡🫁 Check out the top takeaways ⏬
Are you a recent/soon-to-be PhD graduate in immunology or a related field? Want to develop novel therapeutics for lung disease/lung transplantation? We are looking for postdoctoral fellow through the the UHN Canada Leads opportunity https://t.co/qL4O5wJ4wE. Please get in touch!